1. An Exercise Mimetic Approach to Reduce Poststroke Deconditioning and Enhance Stroke Recovery. (June 2021) Authors: McDonald, Matthew W.; Jeffers, Matthew S.; Issa, Lama; Carter, Anthony; Ripley, Allyson; Kuhl, Lydia M.; Morse, Cameron; Comin, Cesar H.; Jasmin, Bernard J.; Lacoste, Baptiste; Corbett, Dale Journal: Neurorehabilitation & neural repair Issue: Volume 35:Number 6(2021) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression. Issue 9 (3rd May 2018) Authors: Péladeau, Christine; Adam, Nadine J.; Jasmin, Bernard J. Journal: FASEB journal Issue: Volume 32:Issue 9(2018) Page Start: 5090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combinatorial therapies for rescuing myotonic dystrophy type 1 skeletal muscle defects. Issue 6 (June 2022) Authors: Ravel-Chapuis, Aymeric; Jasmin, Bernard J. Journal: Trends in molecular medicine Issue: Volume 28:Issue 6(2022) Page Start: 439 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Critical Assessment of the mdx Mouse with Ex Vivo Eccentric Contraction of the Diaphragm Muscle. Issue 3 (14th August 2018) Authors: Addicks, Gregory C.; Marshall, Phillip; Jasmin, Bernard J.; Renaud, Jean‐Marc; Zhang, Hongbo; Menzies, Keir J. Editors: Auwerx, Johan; Ackerman, Susan L.; Brown, Stephen D.; Justice, Monica J.; Nadeau, Joseph Journal: Current protocols in mouse biology Issue: Volume 8:Issue 3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Expression of Pannexin 1 and Pannexin 3 during skeletal muscle development, regeneration, and Duchenne muscular dystrophy. Issue 10 (10th May 2018) Authors: Pham, Tammy L.; St‐Pierre, Marie‐Eve; Ravel‐Chapuis, Aymeric; Parks, Tara E. C.; Langlois, Stéphanie; Penuela, Silvia; Jasmin, Bernard J.; Cowan, Kyle N. Journal: Journal of cellular physiology Issue: Volume 233:Issue 10(2018:Oct.) Page Start: 7057 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Metformin increases peroxisome proliferator–activated receptor γ Co‐activator‐1α and utrophin a expression in dystrophic skeletal muscle. Issue 1 (14th May 2015) Authors: Ljubicic, Vladimir; Jasmin, Bernard J. Journal: Muscle & nerve Issue: Volume 52:Issue 1(2015:Jul.) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacological and exercise‐induced activation of AMPK as emerging therapies for myotonic dystrophy type 1 patients. (28th June 2022) Authors: Ravel‐Chapuis, Aymeric; Duchesne, Elise; Jasmin, Bernard J. Journal: Journal of physiology Issue: Volume 600:Number 14(2022) Page Start: 3249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. RNA binding protein RALY promotes Protein Arginine Methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells. (October 2017) Authors: Bondy-Chorney, Emma; Baldwin, R. Mitchell; Didillon, Andréanne; Chabot, Benoît; Jasmin, Bernard J.; Côté, Jocelyn Journal: International journal of biochemistry & cell biology Issue: Volume 91:Part B(2017) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Sex‐dependent role of Pannexin 1 in regulating skeletal muscle and satellite cell function. Issue 10 (8th August 2022) Authors: Freeman, Emily; Langlois, Stéphanie; Scott, Kaylee; Ravel‐Chapuis, Aymeric; Jasmin, Bernard J.; Cowan, Kyle N. Journal: Journal of cellular physiology Issue: Volume 237:Issue 10(2022) Page Start: 3944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Staufen1s role as a splicing factor and a disease modifier in Myotonic Dystrophy Type I. Issue 1 (1st January 2016) Authors: Bondy-Chorney, Emma; Crawford Parks, Tara E.; Ravel-Chapuis, Aymeric; Jasmin, Bernard J.; Côté, Jocelyn Journal: Rare diseases Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗